Chemical constituents from the seeds of Nigella glandulifera and their hypoglycemic activities

Qingqing Li,Jing Xu,Yiyu Chen,Wenli Xie,Gui Mei,Xueni Li,Yu Chen,Guangzhong Yang
DOI: https://doi.org/10.1039/d2ra02628g
IF: 4.036
2022-07-06
RSC Advances
Abstract:The seeds of Nigella glandulifera Freyn et Sint. are traditional Uygur medicine used for the treatment of diabetes. However, the active anti-diabetic constituents in the seeds of N. glandulifera remain unclear. In the present study, a new delabellane-type diterpene, 8-denicotinoylnigellamine A1 ( 1 ), and a new acyclic sesquiterpene, 2,6,10-trimethyl-6,7,12-trihydroxy-dodec-2-ene ( 3 ), together with eight known compounds including alkaloids ( 2 and 7 ), triterpenoid saponins ( 4–6 ), and phenolic compounds ( 8–10 ), were isolated from the seeds of N. glandulifera . Their structures were determined by extensive spectroscopic analyses and quantum chemical calculations. We evaluated the potential protective effects of the isolated compounds on an insulin resistant HepG2 (IR-HepG2) cell model. The results showed that compounds 2 , 4–8 , and 10 could promote the consumption of glucose in IR-HepG2 cells. Those compounds might be responsible for the anti-diabetic effects of the seeds of N. glandulifera .
chemistry, multidisciplinary
What problem does this paper attempt to address?